Treatment with anti-ErbB2 antibody combinations
作者： Camellia W. Adams , Leonard G. Presta , Mark Sliwkowski
DOI:
关键词:
摘要: The present application describes methods for treating ErbB-expressing cancer with anti-ErbB2 antibody combinations.
lens.org参考文章(197)
T Lam, K L Trimpe, P J Marks, W P Carney, S J McKenzie, J Morgan, D L Panicali, Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene. ,vol. 4, pp. 543- 548 ,(1989)
Drebin Ja, Link Vc, Greene Mi, Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. Oncogene. ,vol. 2, pp. 273- ,(1988)
A D Seidman, L Norton, J Baselga, P P Rosen, HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. Oncology. ,vol. 11, pp. 43- 48 ,(1997)
C. R. King, I. Borrello, F. Bellot, P. Comoglio, J. Schlessinger, Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. The EMBO Journal. ,vol. 7, pp. 1647- 1651 ,(1988) , 10.1002/J.1460-2075.1988.TB02991.X
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Jeffrey A. Kern, Mark Sliwkowski, Use of heregulin as an epithelial cell growth factor ,(1999)
Elizabeth Sophia Light, Albert Louis George, Mary Ge Wang, Methods for the detection of chromosome structural abnormalities by in situ hybridization to fixed tissue ,(1993)
John W. Brandis, Michael P. Mcbrogan, Deborah L. Parkes, Laura K. Shawver, Hsiao-Lai C. Liu, RECOMBINANT AND CHIMERIC ANTIBODIES TO c-erbB-2 ,(1992)
Hans-Jörg Dr. Bühring, Inhibiting growth of leukemic cells by targeting HER-2 protein ,(1995)